JESSICA STITH: Open Payments
NPI 1427788413 · LA GRANGE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,083 in 329 payments from 22 companies in 2025. Trend: 2023 $2,733 · 2024 $5,175 · 2025 $6,083
Food & beverage: $4,813Speaker / faculty: $1,260Education: $10
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 70 | $1,996 |
| Janssen Biotech, Inc. | 56 | $957 |
| ABBVIE INC. | 58 | $880 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 40 | $511 |
| Madrigal Pharmaceuticals | 15 | $377 |
| GENZYME CORPORATION | 13 | $292 |
| Ardelyx, Inc. | 26 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $197 |
| QOL Medical, LLC | 9 | $143 |
| Ipsen Biopharmaceuticals, Inc | 11 | $141 |
Products named: VOQUEZNA, TREMFYA, RINVOQ, XIFAXAN, DUPIXENT, REZDIFFRA, IBSRELA, ENTYVIO.
Industry payments across KY — which companies pay providers there.
